Pfizer: Best Trading Momentum Since 2021 And 6% Yield


  • Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear.
  • An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist.
  • PFE stock could prove one of the smartest defensive plays to own the rest of 2024 and into 2025, given a major bear market selloff is next for Wall Street.


Simfo/E+ via Getty Images

Pfizer (NYSE:PFE)(NEOE:PFE:CA) has been a losing investment idea for several years, really since peak pandemic demand was reached for its leading COVID vaccines and antiviral prescription drugs. I have mentioned the stock several

Analyst’s Disclosure: I/we have a beneficial long position in the shares of PFE, SNY, GILD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This writing is for educational and informational purposes only. All opinions expressed herein are not investment recommendations and are not meant to be relied upon in investment decisions. The author is not acting in an investment advisor capacity and is not a registered investment advisor. The author recommends investors consult a qualified investment advisor before making any trade. Any projections, market outlooks, or estimates herein are forward-looking statements based upon certain assumptions that should not be construed as indicative of actual events that will occur. This article is not an investment research report, but an opinion written at a point in time. The author's opinions expressed herein address only a small cross-section of data related to an investment in securities mentioned. Any analysis presented is based on incomplete information and is limited in scope and accuracy. The information and data in this article are obtained from sources believed to be reliable, but their accuracy and completeness are not guaranteed. The author expressly disclaims all liability for errors and omissions in the service and for the use or interpretation by others of information contained herein. Any and all opinions, estimates, and conclusions are based on the author's best judgment at the time of publication and are subject to change without notice. The author undertakes no obligation to correct, update or revise the information in this document or to otherwise provide any additional materials. Past performance is no guarantee of future returns.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Leave a Reply

Your email address will not be published. Required fields are marked *